A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Starting soon · Not applicable

Conditions studied: Lymphoma

In brief

The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.

Key facts

Study ID

NCT07013435

Run by

Massachusetts General Hospital

People needed

254

Starts

2026-07-20

Expected to finish

2030-08-01

Last updated by the study team

2026-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• English or Spanish speaking adults (18+ at time of enrollment)
• Within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy, immunotherapy, radiation therapy, or other)

You may not qualify if…

• Active psychiatric or cognitive comorbidity as determined by the site PI or treating clinician

Where it is running

• Mass General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.